Author: Kerry Malak
Not long ago, when a dog was diagnosed with lymphoma, one of the most common forms of canine cancer, pet
guardians had little reason to hope for a cure. With success rates of less than 2% and remission times lasting on
average just over 12 months, current chemotherapy protocols have not been able to offer much promise of long
term success. But, a new method of treating dogs with lymphoma is changing all of that.
Doctors at North Carolina State University’s Veterinary Teaching Hospital are now using bone marrow
transplants (BMT) to treat canine patients with lymphoma – a new application of an existing technology
responsible for saving the lives of thousands of humans each year.
Read more from this special report prepared for K9 Magazine.